npj Digital Medicine:数字健康设备的选择:更多并不意味着更好

2019-06-21 佚名 BMC期刊

已有许多例子表明,数字健康的创新不一定能在现实中创造价值。通常的原因是核心的传感器或应用程序不适合相关应用。那么我们能否以更好的方式处理这个问题,以便提高数字健康创新发明走向应用的成功率?近期发表在npj Digital Medicine 上的一篇文章试图给出答案。

已有许多例子表明,数字健康的创新不一定能在现实中创造价值。通常的原因是核心的传感器或应用程序不适合相关应用。那么我们能否以更好的方式处理这个问题,以便提高数字健康创新发明走向应用的成功率?近期发表在npj Digital Medicine 上的一篇文章试图给出答案。

如今,衡量人类各方面的绩效和行为有着巨大的市场, 而数字设备在其中的使用拥有更大的市场潜力。无论是医疗还是消费的健康设备,都在创造大量的研究和商业机会。然而,对于在寻求合适设备的数字健康专业人士来说,多样的选择也带来了很多困扰,比如哪种设备是最可靠的、最准确的、有实证基础且可用性强?而哪一种最适合自己的研究或所提供的服务?这些是专业人士面临的问题,但遗憾的是,目前没有一个标准化的方法可以帮助他们筛选、评估和比较大量可用的设备,以找到最合适的选择。

这一过程的缺失可能导致一系列问题。我们在数字医疗领域中会经常遇到这种情况,所选择的设备被发现有问题,并不一定意味着设备本身出了错。通常情况下都是发生在我们做出选择的时候,在挑选时并没有根据服务提供商或者用户的特定需求来选择相关设备。例如,按键特别小的设备可能就不适合手指不灵活的老年人使用,也会导致他们拒绝使用这样的设备。然而,这种人为因素通常是在已经决定进行投资或开始生产后才发现的。所以,在选择时深入了解和优先考虑人们对应用的要求尤为重要。我们建议在设备购买之前就进行评估,让应用需求成为选择设备的驱动力。

我们的论文提供了一个用来评估健康设备的框架,旨在解决上述问题。此框架通过三个步骤系统严谨地指导专业人员:(1)定义需求,(2)搜索设备和(3)评估设备。框架的目的是帮助专业人员避免在不适合的设备上投资,并为他们提供可以满足用户需求的最佳设备选择。这并不意味着我们推荐的方法是解决此问题的“最佳”或唯一途径,但是我们正在向数字健康研究界推荐这一评估框架,贡献一种解决该问题的方式,并希望得到如何改进的反馈。毕竟,所有的传感器各有不同,但我们希望我们的评估人体性能设备的框架能够帮助那些试图找出最佳设备的人向前迈出一步。

原始出处:
Brian Caulfield, Brenda Reginatto & Patrick Slevin. Not all sensors are created equal: a framework for evaluating human performance measurement technologies. npj Digital Medicine. Feb 2019.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1784332, encodeId=836e1e84332c2, content=<a href='/topic/show?id=98275961cd' target=_blank style='color:#2F92EE;'>#digital#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5961, encryptionId=98275961cd, topicName=digital)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae2431, createdName=venlin, createdTime=Mon Aug 26 02:11:00 CST 2019, time=2019-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858970, encodeId=51a118589e0d1, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Wed Jun 03 12:11:00 CST 2020, time=2020-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1773798, encodeId=644d1e737984c, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Sat Jun 29 18:11:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1577675, encodeId=c57e15e7675a2, content=<a href='/topic/show?id=cda91148004' target=_blank style='color:#2F92EE;'>#Medicine#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11480, encryptionId=cda91148004, topicName=Medicine)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54cd16396700, createdName=ms1692212821629096, createdTime=Sun Jun 23 14:11:00 CST 2019, time=2019-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609831, encodeId=649416098313e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jun 23 14:11:00 CST 2019, time=2019-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368133, encodeId=27e636813351, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Jun 22 00:18:17 CST 2019, time=2019-06-22, status=1, ipAttribution=)]
    2019-08-26 venlin
  2. [GetPortalCommentsPageByObjectIdResponse(id=1784332, encodeId=836e1e84332c2, content=<a href='/topic/show?id=98275961cd' target=_blank style='color:#2F92EE;'>#digital#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5961, encryptionId=98275961cd, topicName=digital)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae2431, createdName=venlin, createdTime=Mon Aug 26 02:11:00 CST 2019, time=2019-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858970, encodeId=51a118589e0d1, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Wed Jun 03 12:11:00 CST 2020, time=2020-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1773798, encodeId=644d1e737984c, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Sat Jun 29 18:11:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1577675, encodeId=c57e15e7675a2, content=<a href='/topic/show?id=cda91148004' target=_blank style='color:#2F92EE;'>#Medicine#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11480, encryptionId=cda91148004, topicName=Medicine)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54cd16396700, createdName=ms1692212821629096, createdTime=Sun Jun 23 14:11:00 CST 2019, time=2019-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609831, encodeId=649416098313e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jun 23 14:11:00 CST 2019, time=2019-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368133, encodeId=27e636813351, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Jun 22 00:18:17 CST 2019, time=2019-06-22, status=1, ipAttribution=)]
    2020-06-03 jeanqiuqiu
  3. [GetPortalCommentsPageByObjectIdResponse(id=1784332, encodeId=836e1e84332c2, content=<a href='/topic/show?id=98275961cd' target=_blank style='color:#2F92EE;'>#digital#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5961, encryptionId=98275961cd, topicName=digital)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae2431, createdName=venlin, createdTime=Mon Aug 26 02:11:00 CST 2019, time=2019-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858970, encodeId=51a118589e0d1, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Wed Jun 03 12:11:00 CST 2020, time=2020-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1773798, encodeId=644d1e737984c, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Sat Jun 29 18:11:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1577675, encodeId=c57e15e7675a2, content=<a href='/topic/show?id=cda91148004' target=_blank style='color:#2F92EE;'>#Medicine#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11480, encryptionId=cda91148004, topicName=Medicine)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54cd16396700, createdName=ms1692212821629096, createdTime=Sun Jun 23 14:11:00 CST 2019, time=2019-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609831, encodeId=649416098313e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jun 23 14:11:00 CST 2019, time=2019-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368133, encodeId=27e636813351, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Jun 22 00:18:17 CST 2019, time=2019-06-22, status=1, ipAttribution=)]
    2019-06-29 kalseyzl
  4. [GetPortalCommentsPageByObjectIdResponse(id=1784332, encodeId=836e1e84332c2, content=<a href='/topic/show?id=98275961cd' target=_blank style='color:#2F92EE;'>#digital#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5961, encryptionId=98275961cd, topicName=digital)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae2431, createdName=venlin, createdTime=Mon Aug 26 02:11:00 CST 2019, time=2019-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858970, encodeId=51a118589e0d1, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Wed Jun 03 12:11:00 CST 2020, time=2020-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1773798, encodeId=644d1e737984c, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Sat Jun 29 18:11:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1577675, encodeId=c57e15e7675a2, content=<a href='/topic/show?id=cda91148004' target=_blank style='color:#2F92EE;'>#Medicine#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11480, encryptionId=cda91148004, topicName=Medicine)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54cd16396700, createdName=ms1692212821629096, createdTime=Sun Jun 23 14:11:00 CST 2019, time=2019-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609831, encodeId=649416098313e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jun 23 14:11:00 CST 2019, time=2019-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368133, encodeId=27e636813351, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Jun 22 00:18:17 CST 2019, time=2019-06-22, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1784332, encodeId=836e1e84332c2, content=<a href='/topic/show?id=98275961cd' target=_blank style='color:#2F92EE;'>#digital#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5961, encryptionId=98275961cd, topicName=digital)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae2431, createdName=venlin, createdTime=Mon Aug 26 02:11:00 CST 2019, time=2019-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858970, encodeId=51a118589e0d1, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Wed Jun 03 12:11:00 CST 2020, time=2020-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1773798, encodeId=644d1e737984c, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Sat Jun 29 18:11:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1577675, encodeId=c57e15e7675a2, content=<a href='/topic/show?id=cda91148004' target=_blank style='color:#2F92EE;'>#Medicine#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11480, encryptionId=cda91148004, topicName=Medicine)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54cd16396700, createdName=ms1692212821629096, createdTime=Sun Jun 23 14:11:00 CST 2019, time=2019-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609831, encodeId=649416098313e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jun 23 14:11:00 CST 2019, time=2019-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368133, encodeId=27e636813351, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Jun 22 00:18:17 CST 2019, time=2019-06-22, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1784332, encodeId=836e1e84332c2, content=<a href='/topic/show?id=98275961cd' target=_blank style='color:#2F92EE;'>#digital#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5961, encryptionId=98275961cd, topicName=digital)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aae2431, createdName=venlin, createdTime=Mon Aug 26 02:11:00 CST 2019, time=2019-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1858970, encodeId=51a118589e0d1, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Wed Jun 03 12:11:00 CST 2020, time=2020-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1773798, encodeId=644d1e737984c, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Sat Jun 29 18:11:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1577675, encodeId=c57e15e7675a2, content=<a href='/topic/show?id=cda91148004' target=_blank style='color:#2F92EE;'>#Medicine#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11480, encryptionId=cda91148004, topicName=Medicine)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54cd16396700, createdName=ms1692212821629096, createdTime=Sun Jun 23 14:11:00 CST 2019, time=2019-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609831, encodeId=649416098313e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jun 23 14:11:00 CST 2019, time=2019-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=368133, encodeId=27e636813351, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Jun 22 00:18:17 CST 2019, time=2019-06-22, status=1, ipAttribution=)]
    2019-06-22 飛歌

    学习了很有用不错

    0

相关资讯

昆山杜克大学办智慧健康论坛:数字创新如何改善医疗保健业

科技好像让减肥变得更容易了——瞧瞧手机上那些五花八门的减肥App和可穿戴设备吧。可情况真是如此吗?在10月14日昆山杜克大学举办的国际智慧健康论坛上,长期研究健康减肥项目的杜克大学教授Gary Bennett给出的答案是,其实不然。Gary教授对记者表示,由于缺乏即时反馈、个性化提示与来自专业人士相应的方案调整,这些App与手环也许并不像人们的设计初衷一样,能帮助到减肥。更早之前,一份发表于《美国

CES的数字健康焦点:睡眠健康、区块链、数据共享、服务收费方式

2018年拉斯维加斯的消费电子展(CES)上,睡眠健康、区块链、数据共享、服务收费方式等成为焦点话题。

FDA2018规划发布 多条涉及数字健康领域

美国食品和药物管理局(Food and Drug Administration FDA)局长斯科特·戈特利布(Scott Gottlieb)近日宣布:“应对阿片类药物滥用与成瘾危机,利用创新与竞争技术改善医疗卫生现状,教育消费者更好地选择营养以降低发病率和死亡率,加强风险管理工具,是2018年FDA规划图的四大基石。”

Health + HealthKit,苹果在数字健康将效仿iTunes模式?

苹果公司周二在WWDC开发者大会上发布了新的健康应用Health,同时也推出了一个新的健康数据库HealthKit。 Health加上HealthKit,这可能意味着苹果在数字健康市场将效仿其在数字音乐市场的成功模式,即iTunes模式。 调研公司Reticle Research分析师罗斯·鲁宾(Ross Rubin)称:“很明显苹果今天种下了种子,尽管没有发布任何硬件,这与当初的iTunes

关于数字健康 FDA在 2018是这样规划的

美国食品和药物管理局(Food and Drug  Administration  FDA)局长斯科特·戈特利布(Scott Gottlieb)近日宣布:“应对阿片类药物滥用与成瘾危机,利用创新与竞争技术改善医疗卫生现状,教育消费者更好地选择营养以降低发病率和死亡率,加强风险管理工具,是2018年FDA规划图的四大基石。”为此,FDA启动了“生物仿制药创新计划”,以便更好地激励

盘点:2014年FDA批准的23个数字健康App和设备

美国医疗健康资讯网站MobiHealthNews已连续数年追踪FDA对智能手机连接的医疗设备和独立应用程序(App)的审批情况。2014年度,迄今为止,FDA已批准了23个与数字健康相关的App和设备。 第一季度:7款 Kinsa Health公司——Kinsa智能温度计,可用于口腔、下臂或直肠,该设备将数据传送到一个伴侣智能手机app。 三星(Samsung)公司——S Health ap